Glutamic acid decarboxylase antibody-spectrum disorders and type 1 diabetes mellitus in a patient following allogenic hematopoietic cell transplantation with review of literature
Glutamic acid decarboxylase (GAD) is an enzyme that catalyzes the conversion of glutamic acid into γ-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the central nervous system (CNS). GAD is widely expressed in the CNS and pancreatic β-cells. GABA produced by GAD plays a role in...
Saved in:
| Main Authors: | Shinichiro Sano, Taemi Ogura, Takayuki Takachi, Yuki Murai, Yasuko Fujisawa, Tsutomu Ogata, Kenichiro Watanabe, Masaki Yoshimura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Japan Endocrine Society
2025-03-01
|
| Series: | Endocrine Journal |
| Subjects: | |
| Online Access: | https://www.jstage.jst.go.jp/article/endocrj/72/3/72_EJ24-0457/_html/-char/en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Limbic autoimmune encephalitis with antibodies to glutamate decarboxylase (GAD)
by: L. U. Ulukhanova, et al.
Published: (2020-06-01) -
Wolbachia infection confers post-translational modification of glutamic acid decarboxylase and other proteins in D. melanogaster
by: Sarah M. Boothman, et al.
Published: (2025-06-01) -
AUTOANTIBODIES TO GLUTAMIC ACID DECARBOXYLASE AS A PATHOGENETIC MARKER OF TYPE I DIABETES MELLITUS
by: N. V. Piven, et al.
Published: (2014-07-01) -
Activation of dopamine 2 receptors modulates glutamate decarboxylases 65 and 67 during stroke recovery in mice
by: Daniela Talhada, et al.
Published: (2023-12-01) -
Successful treatment of stiff-person syndrome with plasmapheresis: case report and literature review
by: M. Nasvytis, et al.
Published: (2023-10-01)